2005
DOI: 10.7150/ijbs.1.51
|View full text |Cite
|
Sign up to set email alerts
|

The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits

Abstract: A Ab bs st tr ra ac ct t The heterotrimeric G-protein alpha subunit has long been considered a bimodal, GTP-hydrolyzing switch controlling the duration of signal transduction by seven-transmembrane domain (7TM) cell-surface receptors.In 1996, we and others identified a superfamily of "regulator of G-protein signaling" (RGS) proteins that accelerate the rate of GTP hydrolysis by Gα subunits (dubbed GTPase-accelerating protein or "GAP" activity). This discovery resolved the paradox between the rapid physiologica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

7
408
1
1

Year Published

2005
2005
2017
2017

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 383 publications
(417 citation statements)
references
References 160 publications
7
408
1
1
Order By: Relevance
“…Second, G proteins are an ideal target for therapeutic intervention because they serve as signal amplification switches, and potent and pathway-selective activators/inhibitors of a G protein can serve multiple purposes ranging from being a research tool to pharmacologic probe for use in experimental and clinical therapeutics (36). The technique we define here allows exogenous manipulation of the RTK-GIV-Gi pathway by enhancing or suppressing the coupling of G protein with RTKs and their subsequent transactivation, in a dose-dependent manner while minimizing the risk of tampering with other physiologic functions/interactions of G proteins/or other components within the network of modulators of G protein signaling (37).…”
Section: Resultsmentioning
confidence: 99%
“…Second, G proteins are an ideal target for therapeutic intervention because they serve as signal amplification switches, and potent and pathway-selective activators/inhibitors of a G protein can serve multiple purposes ranging from being a research tool to pharmacologic probe for use in experimental and clinical therapeutics (36). The technique we define here allows exogenous manipulation of the RTK-GIV-Gi pathway by enhancing or suppressing the coupling of G protein with RTKs and their subsequent transactivation, in a dose-dependent manner while minimizing the risk of tampering with other physiologic functions/interactions of G proteins/or other components within the network of modulators of G protein signaling (37).…”
Section: Resultsmentioning
confidence: 99%
“…The members of the third group, non-receptor GEFs, are a heterogeneous group of cytosolic proteins that accelerate GDP to GTP exchange, and thereby, cause activation of Ga subunits through a non-canonical mechanism, independently of GPCRs or Gbg dimers. [7][8][9][10][11] These fundamentals have been described in-depth in a widely-cited review by Siderovski and Willard 6 over a decade ago. In the years since, a growing body of work by us and others indicates that genetic or epigenetic factors that deregulate the intricate network of "accessory proteins" in a variety of disease states are just as significant as those that directly affect the G proteins and GPCRs, if not more so.…”
mentioning
confidence: 95%
“…The intrinsic GTPase activity of Ga causes hydrolysis of the bound GTP and regenerates GDP·Gabg, completing one signaling cycle (CabreraVera et al, 2003;Offermanns, 2003;Urano et al, 2013). REGULATOR OF G-PROTEIN SIGNALING (RGS) domain-containing proteins, which enhance the GTPase activity of Ga, accelerate the rate of the G-protein cycle (Siderovski and Willard, 2005).…”
mentioning
confidence: 99%